About Intermolecular
Intermolecular is an Industrial Goods & Manufacturing company based in San Jose (United States) founded in 2004, and was acquired by Merck in May 2019. Materials development consulting is offered for semiconductor and electronics sectors. Intermolecular has raised $62.62 million across 3 funding rounds from investors including Merck, Symyx Technologies and Redpoint Ventures. The company has 83 employees. The company was acqui-hired. Its focus areas include Chemicals and Materials Tech, Materials Tech, Research and Development and Tech Enabled Services. Its legal entity is INTERMOLECULAR INC. Its competitors include DUJUD and Stoicheia; 1 of its 2 listed competitors has raised funding.
Company details
Intermolecular partner with other companies to help them in developing materials for applications in industries like semiconductor, consumer electronics, automotive and aerospace. The company uses its experimentation platform, information and analytics infrastructure to help companies accelerate material innovation. They have a Materials and Device simulation group that supports material innovation using empirical data DFT simulations which provide vital information about the key material properties and atomic for further thermodynamic and device-level modelling, using both commercial and in-house tools.
- Headquarters San Jose, United States
- Employees 83
- Stage Public
- SectorsIndustrial Goods & Manufacturing
- Email••••••••
- Website intermolecular.com
- Social LinkedIn
- Acquired by Merck (May 2019)
- Legal Name Intermolecular Inc.
Funding Insights of Intermolecular
Intermolecular has successfully raised a total of $62.62M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $62.62M
- Total Rounds 3
- Last Round Series D — $15M
- First Round $27.62M
(Sep 2006)
- Investors Count 4
All 3 funding rounds of Intermolecular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $15M | Series D | – | – | – |
| Jan 2009 | $20M | Series D | – | – | |
| Sep 2006 | $27.62M | Series C | – | – |
5 investors in total: 5 institutional.
Investors in Intermolecular
Intermolecular has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, Symyx Technologies and Redpoint Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Redpoint Ventures is engaged in venture capital investments. | redpoint.com | Woodside, United States | ||
| cmea.com | ||||
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Informatics and automation products for research are offered. | 1994 | symyx.com | San Diego, United States | |
Merck is engaged in science and technology solutions globally. | 1668 | merckgroup.com | Darmstadt, Germany |
Investor details for Intermolecular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Intermolecular
546 people are tracked at Intermolecular (254 in leadership, 292 in team); the tracked headcount is 83.
| Name | Role | Group |
|---|---|---|
Chris Minnich | Director, Coe Devices | Leadership |
Josie Downey | General Manager And Managing Director, Merck Healthcare, Australia And New Zealand | Leadership |
Bianca Rehpenning | Director | Leadership |
Rajesh Neelakanta | Associate Director - IT Business Partner | Leadership |
Delphine Lonfat Corsat | Head Of Talent, Rewards & Analytics Healthcare Sector | Leadership |
Clorinde Lacroix Hirt | Head Of Device Quality System | Leadership |
Nitish Kumar | Head Of Customer Application , Downstream, India | Leadership |
John Lee | Managing Director, Merck Group In Taiwan | Leadership |
Pierluigi Mega | Director - Head Of Smart Process Automation | Leadership |
Daniel Hookins | Gillingham Site Director And Head Of UK Distribution | Leadership |
Theresa Schlottmann | Head Of Market Positioning In Single Use & Integrated Platform Solutions | Leadership |
Lucile Martin | HR Business Partner | Leadership |
Renaut Damien | Head Of HR Australia NZ & South East Asia | Leadership |
Benjamin Kirchner | Director / Head Of ERP Architecture & Cross-services | Leadership |
Prashant Kumar | Head Of M&s Web Channel | Leadership |
Romina Marcovici | Director - Head Of Marketing Strategy Biomonitoring | Leadership |
Laurence Carudel | Head Of Segment Marketing Communication | Leadership |
Cordelia Morcos | Head Of Talent Management Enabling Functions | Leadership |
Nuno Miguel Piedade Silverio | Market Access Director | Leadership |
Kai Zinn | Senior Vice President, Sustainability Management | Leadership |
526 more people are available in the full profile.
Complete people profiles for Intermolecular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Intermolecular
5 dated milestones of Intermolecular across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Intermolecular is founded.
- Funding First funding round of $27.6M.
- Funding Latest funding round, Series D, of $15.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Merck.
Competitors of Intermolecular
Intermolecular has 2 listed competitors in our database, 1 of them funded. They include DUJUD and Stoicheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dujud.com | 2019 | Atlanta, United States | 3D-printed micro-electronic systems, including circuit boards and sensors, are developed. | |||
| stoicheia.ai | 2020 | Skokie, United States | $5M | Provider of AI-enabled diverse nanomaterials |
Detailed competitors of Intermolecular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Intermolecular
Websites that share an audience with Intermolecular (intermolecular.com).
Websites whose visitors overlap most with Intermolecular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sequoiacap.com | 100% | #105,514 | View details | ||
| legacyventure.com | 100% | View details | |||
| mosys.com | 66% | View details | |||
| sjwater.com | 66% | 79.4K | #570,643 | View details | |
| svb.com | 66% | 446.4K | #73,009 | View details |
Top companies in Materials Equipment & Tech
3 companies that operate in the same segment as Intermolecular (Materials Equipment & Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Schrödinger is recognized for developing physics-based software platforms for molecular discovery. | 1990 | New York, New York, United States | USD 162 M | USD 255.87 M | 891 | |
Critical minerals are recovered from e-waste via electro-extraction technology. | 2017 | Knoxville, Tennessee, United States | USD 65.23 M | |||
Provider of AI-based solutions for materials informatics | 2013 | Redwood City, California, United States | USD 81.26 M | 53 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intermolecular
Complete news archive for Intermolecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intermolecular
Intermolecular was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Intermolecular is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Intermolecular is a funded company, having raised a total of $62.62M across 3 funding rounds to date. The company's 1st funding round was a Series C of $27.62M, raised on Sep 2006.
Intermolecular has 83 employees.
Intermolecular partner with other companies to help them in developing materials for applications in industries like semiconductor, consumer electronics, automotive and aerospace. The company uses its experimentation platform, information and analytics infrastructure to help companies accelerate material innovation. They have a Materials and Device simulation group that supports material innovation using empirical data DFT simulations which provide vital information about the key material properties and atomic for further thermodynamic and device-level modelling, using both commercial and in-house tools.
Intermolecular has 5 investors. Key investors include Merck, Symyx Technologies, Redpoint Ventures, CMEA Capital, and USVP.
Intermolecular operates through Intermolecular Inc..
Yes. Intermolecular was acquired by Merck in May 2019.